Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations.

Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T.

Oncogene. 2018 May 16. doi: 10.1038/s41388-018-0303-3. [Epub ahead of print] Review.

PMID:
29765155
2.

Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions.

Nikitakis NG, Rassidakis GZ, Tasoulas J, Gkouveris I, Kamperos G, Daskalopoulos A, Sklavounou A.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):637-649. doi: 10.1016/j.oooo.2018.03.006. Epub 2018 Mar 22.

PMID:
29705090
3.

Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm.

Xiao P, Dolinska M, Sandhow L, Kondo M, Johansson AS, Bouderlique T, Zhao Y, Li X, Dimitriou M, Rassidakis GZ, Hellström-Lindberg E, Minato N, Walfridsson J, Scadden DT, Sigvardsson M, Qian H.

Blood Adv. 2018 Mar 13;2(5):534-548. doi: 10.1182/bloodadvances.2017013599.

4.

Expression Analysis of miR-29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype-Related Expression Status.

Papachristopoulou G, Papadopoulos EI, Nonni A, Rassidakis GZ, Scorilas A.

Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30493-7. doi: 10.1016/j.clbc.2017.11.007. [Epub ahead of print]

PMID:
29422258
5.

PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.

Atsaves V, Tsesmetzis N, Chioureas D, Kis L, Leventaki V, Drakos E, Panaretakis T, Grander D, Medeiros LJ, Young KH, Rassidakis GZ.

Leukemia. 2017 Jul;31(7):1633-1637. doi: 10.1038/leu.2017.103. Epub 2017 Mar 27. No abstract available.

PMID:
28344319
6.

Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics.

Psatha K, Kollipara L, Voutyraki C, Divanach P, Sickmann A, Rassidakis GZ, Drakos E, Aivaliotis M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 15;1047:2-14. doi: 10.1016/j.jchromb.2016.11.005. Epub 2016 Nov 15. Review.

PMID:
27979587
7.

mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix.

Asimomytis A, Karanikou M, Rodolakis A, Vaiopoulou A, Tsetsa P, Creatsas G, Stefos T, Antsaklis A, Patsouris E, Rassidakis GZ.

Oncol Lett. 2016 Nov;12(5):3234-3240. Epub 2016 Aug 29.

8.

CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma.

Kwiecinska A, Tsesmetzis N, Ghaderi M, Kis L, Saft L, Rassidakis GZ.

Br J Haematol. 2018 Mar;180(5):744-748. doi: 10.1111/bjh.14432. Epub 2016 Nov 23. No abstract available.

PMID:
27879989
9.

The emerging role of CD30 and p53 as novel targets for therapy in anaplastic large cell lymphoma.

Rassidakis GZ, Drakos E.

Front Biosci (Elite Ed). 2016 Jan 1;8:61-71. Review.

PMID:
26709646
10.

Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.

Guo H, Jing L, Cheng Y, Atsaves V, Lv Y, Wu T, Su R, Zhang Y, Zhang R, Liu W, Rassidakis GZ, Wei Y, Nan K, Claret FX.

Hepatology. 2016 Mar;63(3):898-913. doi: 10.1002/hep.28372. Epub 2016 Jan 14.

PMID:
26606000
11.

Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.

Atsaves V, Zhang R, Ruder D, Pan Y, Leventaki V, Rassidakis GZ, Claret FX.

Leukemia. 2015 Nov;29(11):2162-72. doi: 10.1038/leu.2015.127. Epub 2015 May 19.

12.

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.

Kanakis G, Grimelius L, Spathis A, Tringidou R, Rassidakis GZ, Öberg K, Kaltsas G, Tsolakis AV.

Neuroendocrinology. 2015;101(3):211-22. doi: 10.1159/000381061. Epub 2015 Feb 26.

13.

SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.

Moraitis D, Karanikou M, Liakou C, Dimas K, Tzimas G, Tseleni-Balafouta S, Patsouris E, Rassidakis GZ, Kouvaraki MA.

Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.

PMID:
25456951
14.

The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.

Atsaves V, Lekakis L, Drakos E, Leventaki V, Ghaderi M, Baltatzis GE, Chioureas D, Jones D, Feretzaki M, Liakou C, Panayiotidis P, Gorgoulis V, Patsouris E, Medeiros LJ, Claret FX, Rassidakis GZ.

Br J Haematol. 2014 Nov;167(4):514-23. doi: 10.1111/bjh.13079. Epub 2014 Aug 22.

PMID:
25145835
15.

c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.

Leventaki V, Drakos E, Karanikou M, Psatha K, Lin P, Schlette E, Eliopoulos A, Vassilakopoulos TP, Papadaki H, Patsouris E, Medeiros LJ, Rassidakis GZ.

Hum Pathol. 2014 Mar;45(3):565-72. doi: 10.1016/j.humpath.2013.10.024. Epub 2013 Oct 31.

PMID:
24457077
16.

CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.

Gogali F, Paterakis G, Rassidakis GZ, Liakou CI, Liapi C.

Thyroid. 2013 Dec;23(12):1561-8. doi: 10.1089/thy.2012.0560. Epub 2013 Nov 6.

PMID:
23721357
17.

Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.

Gogali F, Paterakis G, Rassidakis GZ, Kaltsas G, Liakou CI, Gousis P, Neonakis E, Manoussakis MN, Liapi C.

J Clin Endocrinol Metab. 2012 May;97(5):1474-82. doi: 10.1210/jc.2011-1838. Epub 2012 Mar 7.

PMID:
22399513
18.

Expression patterns of endothelin-1 and its receptors in colorectal cancer.

Liakou P, Tepetes K, Germenis A, Leventaki V, Atsaves V, Patsouris E, Roidis N, Hatzitheophilou K, Rassidakis GZ.

J Surg Oncol. 2012 Jun 1;105(7):643-9. doi: 10.1002/jso.23017. Epub 2011 Dec 27.

PMID:
22213082
19.

Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas.

Kouvaraki MA, Liakou C, Paraschi A, Dimas K, Patsouris E, Tseleni-Balafouta S, Rassidakis GZ, Moraitis D.

Surgery. 2011 Dec;150(6):1258-65. doi: 10.1016/j.surg.2011.09.022.

PMID:
22136849
20.

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Drakos E, Singh RR, Rassidakis GZ, Schlette E, Li J, Claret FX, Ford RJ Jr, Vega F, Medeiros LJ.

Leukemia. 2011 May;25(5):856-67. doi: 10.1038/leu.2011.28. Epub 2011 Mar 11.

Supplemental Content

Loading ...
Support Center